Age, Biography and Wiki
Kevin Johnson was born on 30 August, 1960 in Holyhead, United Kingdom. Discover Kevin Johnson's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 63 years old?
| Popular As | N/A |
| Occupation | N/A |
| Age | 63 years old |
| Zodiac Sign | Virgo |
| Born | 30 August, 1960 |
| Birthday | 30 August |
| Birthplace | Holyhead, United Kingdom |
| Nationality | United Kingdom |
We recommend you to check the complete list of Famous People born on 30 August. He is a member of famous with the age 63 years old group.
Kevin Johnson Height, Weight & Measurements
At 63 years old, Kevin Johnson height not available right now. We will update Kevin Johnson's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status | |
|---|---|
| Height | Not Available |
| Weight | Not Available |
| Body Measurements | Not Available |
| Eye Color | Not Available |
| Hair Color | Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family | |
|---|---|
| Parents | Not Available |
| Wife | Not Available |
| Sibling | Not Available |
| Children | Not Available |
Kevin Johnson Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Kevin Johnson worth at the age of 63 years old? Kevin Johnson’s income source is mostly from being a successful . He is from United Kingdom. We have estimated Kevin Johnson's net worth , money, salary, income, and assets.
| Net Worth in 2023 | $1 Million - $5 Million |
| Salary in 2023 | Under Review |
| Net Worth in 2022 | Pending |
| Salary in 2022 | Under Review |
| House | Not Available |
| Cars | Not Available |
| Source of Income |
Kevin Johnson Social Network
Timeline
In 2010, Pangenetics was shortlisted for the Newsflow category at the Genesis 2010 Awards and for Management Team of the Year at the Scrip Awards.
Johnson was CEO of PanGenetics before it was acquired by Abbott Laboratories for $170 million in 2009.
From 2004 to 2016, Johnson worked with Index Ventures' Life Sciences team, first as a venture advisor and then as a partner, and in 2016 co-founded medicxi with three other Index partners.
From 1990 onwards, Johnson was one of the team at Cambridge Antibody Technology (CAT), heading up research and in 1997 he was appointed to the board, where he held the posts of Research Director and Chief Technology Officer. Kevin led both the development of CAT's platform technologies, and also their application to the discovery of a number of human antibodies currently in clinical development, including the first such drug, Humira to reach the market. He was also part of the management team that floated CAT on the London Stock Exchange (main market).
Kevin Johnson (born 30 August 1960 in Holyhead, Wales) is a partner at medicxi, a venture capital firm focused on life sciences investments based on the asset-centric approach to investing. He was formerly with Index Ventures, having joined the venture capital firm in 2010.
